Skip to content

Psychosocial Skills Group for Pelvic Floor Symptoms

Piloting a Virtual Education and Psychosocial Skills Group for Postpartum Pelvic Floor Symptoms

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07429539
Enrollment
16
Registered
2026-02-24
Start date
2026-02-17
Completion date
2026-05-19
Last updated
2026-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Floor Awareness, Pelvic Floor Disorder

Keywords

childbirth injuries, pelvic floor conditions

Brief summary

There is a critical need for evidence-based programs that address the educational needs and psychosocial impact of childbirth-related pelvic floor injuries and conditions in an accessible format. The purpose of this pilot study is to develop, implement, and evaluate the feasibility, acceptability, and preliminary effectiveness of a manualized 6-session psychosocial skills and education group for individuals with birth-related pelvic floor injuries and conditions. This group-based approach integrates psychoeducation, pain science, cognitive-behavioral techniques, acceptance-based and mindfulness skills to enhance quality of life and coping skills for those managing these conditions. This research study will test whether a virtual education and psychosocial skills group can provide valuable resources and skill-building for people living with these conditions. The findings from this pilot study will help us understand whether this type of program is feasible, acceptable, and potentially beneficial, and will inform refinement of the group protocol and study procedures in preparation for a future randomized controlled trial.

Interventions

BEHAVIORALEducation and Psychosocial Skills

Participants will attend a 6-session, virtual psychosocial education and skills group, for individuals with birth-related pelvic floor conditions. This is a non-randomized pilot feasibility study. All enrolled participants will receive the same group content, with assessments conducted at baseline (pre-group), brief surveys after each session, and immediately following group completion.

Sponsors

Dartmouth-Hitchcock Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Interested participants are eligible to participate if they: 1. Are experiencing pelvic floor symptoms following vaginal delivery within the past year; this may include urinary or fecal incontinence, pelvic organ prolapse symptoms ("tampon falling out"), and pelvic pain. 2. Believe that their pelvic floor symptoms are negatively impacting wellbeing and quality of life. 3. Are under the care of a medical provider for management of physical symptoms (e.g., pelvic floor PT, urogynecologist, obstetrician gynecologist, primary care clinician, etc). 4. Are English-speaking. 5. Are comfortable participating in a virtual group-based setting.

Exclusion criteria

1. Cognitive disability that prevents participants from understanding and engaging with spoken and written group content 2. Suicidal thoughts or urges to harm oneself 3. Lack of private space to join the group sessions from 4. Current pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Feasibility - retention; number of participants who complete at least four out of six sessionsThrough study completion (average of 8 weeks)
Feasibility - time to complete recruitment (target N=16)Through recruitment completion
Feasibility of the Intervention MeasurePost-test administered immediately after completing 6-week intervention4-item instrument measuring the feasibility of an intervention using a 5-point Likert scale, with higher scores reflecting higher feasibility. Score range: 1-5 (score represents mean of items).
Acceptability - Participant ratings of content relevance and helpfulnessWeekly for 6 weeks
Acceptability of the Intervention MeasurePost-test administered immediately after completing 6-week intervention4-item instrument measuring the acceptability of an intervention using a 5-point Likert scale, with higher scores reflecting greater acceptability. Score range: 1-5 (score represents mean of items).

Secondary

MeasureTime frameDescription
Patient Health QuestionnairePre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention9-item depression measure, with each item scored on a 4-point Likert scale. Score range: 0-27; higher scores reflect more severe depression symptoms.
Perinatal Anxiety Screening ScalePre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention31-item measure of perinatal anxiety, with each item scored on a 4-point Likert scale. Score range: 0-93; higher scores reflect more severe anxiety symptoms.
Barkin Index of Maternal FunctioningPre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention20-item measure of maternal functioning, with each item scored on a 7-point Likert scale. Score range 0-120; higher total scores reflect higher functioning.
University of Washington Self-Efficacy ScalePre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention6-item measure of chronic condition-related self-efficacy, with each item scored on a 5-point Likert scale. Scores range from 6-30; higher scores reflect greater self-efficacy.
Pelvic Floor Impact QuestionnairePre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention21-item measure of pelvic floor symptom-related impact, with each item scored on a 4-point Likert scale. Validated scoring formula results in a total score range of 0-300; higher scores reflect more symptom-related quality of life impairment.
Queensland Female Pelvic Floor QuestionnairePre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention42-item measure of pelvic floor symptom severity and associated level of bother across four categories (bladder function, bowel function, prolapse symtoms, sexual function), with each item scored on a 4-point Likert scale. Scores for each domain range from 0-10; higher scores reflect greater symptom severity.
Brief COPE InventoryPre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention28-items measure of various coping strategies, each item scored on a 4-point Likert scale. Scale scores range from 1-4 (representing mean of items); higher scores on each subscale indicate greater use of that coping strategy.
Female Self Advocacy ScalePre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week interventionFemale Self-Advocacy in Cancer Survivorship Scale (language modified; cancer survivorship --\> pelvic floor symptom management); 20-item measure of health-related self-advocacy, with each item scored on a 6-point Likert scale. Scores range from 20-120; higher scores reflect greater self-advocacy.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 29, 2026